TRT blood panels: Is total testosterone really not enough?

What's this video probably claiming?

Based on the caption and hashtag context, this creator is advising people considering TRT to look beyond a basic total testosterone reading. The argument appears to be that a proper diagnostic workup should include SHBG and albumin (to calculate free testosterone), LH and FSH (to determine whether low testosterone is primary or secondary hypogonadism), and estradiol and prolactin (to assess hormonal balance). A complete blood count is also mentioned. The creator is likely framing this as insider knowledge that most doctors skip, implying patients are being undertreated or misdiagnosed because they only got one number checked. This framing is popular in fitness-adjacent TRT content, and parts of it are genuinely defensible, but the certainty with which these panels are presented as universally necessary deserves scrutiny.

What does the science actually show?

The clinical literature does support a more comprehensive panel than just total testosterone, but with important nuance. The Endocrine Society's 2018 Clinical Practice Guideline (Bhasin et al., Journal of Clinical Endocrinology and Metabolism) recommends confirming low testosterone with at least two morning measurements before any treatment decision, and specifically notes that free testosterone calculation is useful when SHBG is suspected to be abnormal, such as in obesity, liver disease, or older age. LH and FSH are genuinely important: a 2020 review in Translational Andrology and Urology (Corona et al.) confirmed that differentiating primary from secondary hypogonadism changes both prognosis and treatment options significantly. Prolactin is warranted when secondary hypogonadism is confirmed, to rule out pituitary adenoma. Estradiol monitoring during TRT has clinical support, though the optimal target range remains debated. A CBC is standard because exogenous testosterone raises hematocrit, with polycythemia occurring in roughly 3-18% of TRT patients depending on formulation and dose (Nguyen et al., 2018, Drugs).

Where does the social media noise diverge from clinical reality?

The gap between this kind of content and clinical practice is less about the tests themselves and more about how they get interpreted. Fitness-community TRT content often presents free testosterone as a single clean number that reveals the "truth" your doctor missed. In practice, calculated free testosterone uses equations like the Vermeulen formula, which carries its own measurement error and assumes albumin at a fixed 4.3 g/dL. Direct free testosterone assays by equilibrium dialysis are more accurate but expensive and not widely available (Hackney et al., 2019, Frontiers in Endocrinology). There is also a tendency in this space to treat estradiol as something that always needs to be suppressed with an aromatase inhibitor, a practice the Endocrine Society explicitly does not recommend as routine. Prolactin testing is genuinely indicated in secondary hypogonadism, but ordering it as a blanket checkbox for everyone exploring TRT is not the same as targeted clinical reasoning. The panel is not wrong. The confidence that knowing these numbers automatically tells you whether you need TRT often is.

What should you actually know?

If you are considering TRT, the case for a thorough baseline panel is legitimate. Total testosterone alone, especially if drawn in the afternoon or without fasting, can be misleading. SHBG matters more than most people realize: a man with total testosterone of 400 ng/dL and very high SHBG may have less bioavailable hormone than someone at 300 ng/dL with low SHBG. LH and FSH tell your clinician whether your testes are failing or your brain is not signaling properly, and that distinction affects whether testosterone therapy, clomiphene, or further imaging is appropriate. Estradiol and prolactin are reasonable additions when secondary hypogonadism is suspected or when symptoms like gynecomastia or visual changes are present. A CBC at baseline and during treatment is standard practice. What this video almost certainly will not tell you is that symptoms still matter more than any single lab value, and that the American Urological Association's 2018 guidelines (Mulhall et al.) set a diagnostic threshold of consistently below 300 ng/dL combined with symptoms, not just a number in isolation.